Table 3.
Plasmids used in this study
| Plasmid | Characteristic(s) | Source or reference |
|---|---|---|
| pCR-Blunt-TOPO | Invitrogen | |
| TOPO-HindIII-THI3-XhoI-1 | This study | |
| pENTR/D-TOPO | Gateway entry clone | Invitrogen |
| pENTR/D-TOPO-PDC1.3 | Gateway entry clone; PDC1 | This study |
| pENTR/D-TOPO-PDC6.2 | Gateway entry clone; PDC6 | This study |
| pSH65 | URA3 ARSH4 CEN6 Tn5-ble GAL1pr::cre::CYC1ter | 19 |
| pVV214 | Gateway destination vector (URA3 2μm PGK1pr-CYC1ter) | 56 |
| p426-GPD | URA3 2μm TDH3pr-CYC1ter | 42 |
| pUDe001 | URA3 2μm TDH3pr-ARO10-CYC1ter | 60 |
| pUDe002 | URA3 2μm TDH3pr-PDC5-CYC1ter | This study |
| pUDe005 | URA3 2μm TDH3pr-THI3-CYC1ter | This study |
| pEXP214-PDC1.3 | URA3 2μm PGK1pr-PDC1-CYC1ter | This study |
| pEXP214-PDC6.2 | URA3 2μm PGK1pr-PDC6-CYC1ter | This study |